A carboplatin-based regimen for the treatment of patients with advanced transitional cell carcinoma of the urothelium
- 15 October 1996
- Vol. 78 (8) , 1775-1780
- https://doi.org/10.1002/(sici)1097-0142(19961015)78:8<1775::aid-cncr18>3.0.co;2-v
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Carboplatin-based chemotherapy for bladder cancerCancer Treatment Reviews, 1993
- MVAC for bladder cancer: time to move forward again.Journal of Clinical Oncology, 1993
- Carboplatin and 5-fluorouracil in poor performance status patients with advanced urothelial cancerAnnals of Oncology, 1993
- Carboplatin, methotrexate, and vinblastine in patients with bladder cancer who were ineligible for cisplatin-based chemotherapyCancer, 1992
- A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.Journal of Clinical Oncology, 1992
- Carboplatin, Methotrexate and Vinblastin (Carbo-MV) for Advanced Urothelial Cancer A Phase II TrialAmerican Journal of Clinical Oncology, 1991
- A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors.Journal of Clinical Oncology, 1990
- Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapseCancer, 1989
- New Combination Chemotherapy Programme for Bladder CancerBritish Journal of Urology, 1989
- Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study.Journal of Clinical Oncology, 1985